Adocia (France) Today
| ADOC Stock | EUR 4.72 0.10 2.07% |
PerformanceVery Weak
| Odds Of DistressBelow Average
|
Adocia is trading at 4.72 as of the 26th of February 2025, a 2.07% down since the beginning of the trading day. The stock's open price was 4.82. Adocia has about a 37 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 27th of January 2025 and ending today, the 26th of February 2025. Click here to learn more.
Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Adocia SA was founded in 2005 and is headquartered in Lyon, France. The company has 8.9 M outstanding shares. More on Adocia
Moving against Adocia Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Adocia Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Adocia's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Adocia or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Olivier Soula |
| Business Concentration | Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Adocia (ADOC) is traded on Euronext Paris in France and employs 110 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 31.92 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Adocia's market, we take the total number of its shares issued and multiply it by Adocia's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Adocia operates under Biotechnology sector and is part of Health Care industry. The entity has 8.9 M outstanding shares.
Adocia has accumulated about 15.16 M in cash with (19.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.02.
Check Adocia Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Adocia is €31.92 Million. Adocia retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Adocia Ownership Details
Adocia Risk Profiles
Although Adocia's alpha and beta are two of the key measurements used to evaluate Adocia's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.01 | |||
| Standard Deviation | 4.19 | |||
| Variance | 17.55 | |||
| Risk Adjusted Performance | (0.12) |
Adocia Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Adocia without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run ETF Categories Now
ETF CategoriesList of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
| All Next | Launch Module |
Adocia Corporate Directors
| Valerie Danaguezian | Chief Financial Officer, Administrative Director | Profile | |
| Ekaterina Smirnyagina | Independent Director | Profile | |
| Laurent Arthaud | Director Representative of Bpifrance Investissement | Profile | |
| Remi Soula | Co-Founder, Director of Bus. Devel. and Intellectual Property and Scientific Advisor | Profile |
Other Information on Investing in Adocia Stock
Adocia financial ratios help investors to determine whether Adocia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Adocia with respect to the benefits of owning Adocia security.